Miryan, Mahsa
Alavinejad, Pezhman
Abbaspour, Mohammadreza
Soleimani, Davood
Ostadrahimi, Alireza
Funding for this research was provided by:
Tabriz University of Medical Sciences (63292)
Article History
Received: 5 April 2020
Accepted: 15 July 2020
First Online: 5 August 2020
Ethics approval and consent to participate
: The study protocol is drafted in accordance with the SPIRIT checklist and is approved by the Medical Ethics Committee of Tabriz University of Medical Sciences, Tabriz, Iran (ID: IR.TBZMED.REC.1398.473). The current trial is registered at the Iranian Registry of Clinical (ID: IRCT20190708044154N1). The <i>Rome IV Diagnostic Questionnaires</i> were used after obtaining correspondence and authorization under an implied contract not to publish them.The current trial will be conducted in compliance with the Declaration of Helsinki. At the first visit (-t<sub>1</sub>), we will explain to each volunteer the risk and benefit of this trial. We will reassure the volunteers about the confidentiality of their information and expressing the results to them in general at the end of the study and also will answer to their questions regarding this study. Finally, we will publish the research results for the use of other researchers and enthusiasts without mentioning the names and personal details of the individuals at the end of the study. Written informed consent will be obtained from all volunteers before study entry. This intervention will not interfere with the routine treatment of patients with IBS.
: Not applicable.
: The authors declare that they have no competing interests.